Parkinson’s Disease Research and CBD (Cannabidiol)
CBD and Mitochondria: Part One
How This Tag Team Produces Neuroprotective Effects Mitochondria are known as the powerhouses of cells. These small, bean-shaped organelles float freely inside almost every cell in our body, except for red blood cells which contain no mitochondria. The number of mitochondria in an individual cell can vary greatly depending on the tissue type. For example, muscle cells need a lot... ContinueClinical Endocannabinoid Deficiency
Clinical Endocannabinoid Deficiency Could Explain Why You’re Sick Dr. Ethan Russo is one of the world’s foremost experts in cannabis research. Not only is he a board-certified neurologist, psychopharmacology researcher, and an accomplished author in many scientific journals, he’s also the former Senior Medical Advisor to GW Pharmaceuticals – a global leader in the development of cannabis-based medicines. Today, he... ContinueEndocannabinoid System – ECS the Secret To Balanced Health?
The Endocannabinoid System: The Secret To Balanced Health? “I would like to probably push ahead and tell people: Here we have a group of compounds… an endogenous system of major importance… it is not being used as much as it should be in the clinic… it is of great promise in the clinic… let’s try to push it forward.” –... Continue
Parkinson’s Disease Research Continued
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- Prospects for cannabinoid therapies in basal ganglia disorders
- Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties
- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease
- Therapeutic potential of cannabinoids in CNS disease